• 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • Potenza
  • JVS_100_Gene_Therapy_Program Juventas
    fecal incontinence (FI)
  • APP for exercise programs BANDAI NAMCO Entertainment
  • Quethera
    Gene therapy program for glaucoma
  • Rosiptor Aquinox
    IC/BPS
  • Immunostimulating Gene
    Loading Oncolytic Virus
    Tottori University
  • Universal Cells
  • Mitobridge
  • Ogeda
  • MAPS vaccineAffinivax
    Pneumococcal Disease
  • Quetiapine FumarateKyowa
  • AU-935
    Auration
    TMP
  • QutenzaGrünenthal
  • Ganymed
  • ASP015K Topical derma
    Maruho
  • CK-2127107 Cytokinetics ALS
  • MucoRiceUniv of Tokyo
    cholera
  • BAFF/APRIL antagonists
    Thunderbolt pharma
  • AAV-mVChR1Clino
    Retinitis Pigmentosa
  • PSCA/CAR-TBellicum
    Oncology
  • Derma assetsLeo Pharma
  • Ocata
  • LAMP-vaxImmunomic
    Allergy
  • CC-8464Neuropathic Pain
    Chromocell
  • Kanyos Bio Celiac Disease and Type 1 Diabetes
  • Immuno-oncology Therapeutics Potenza
  • SitagliptinMSD
    FDC w/ipragliflozin
  • Monoclonal Antibody MD Anderson
    AML
  • JRC2-LAMP-vaxImmunomic
    JRC pollinosis
  • CK-2127107Cytokinetics
    NMD
  • Dana-Farber Cancer Institute K-Ras-
  • Harvard Medical School RP
  • Cancer Research UK
    Aotophagy
  • ClearPath
  • Transfenic silkworms IBL
  • MitokyneMitochondria
    related disease
  • ASP1941MSD
    Co-promotion
  • IpragliflozinMSD
    Co-promotion
  • ASG-15ME Seattle Genetics
  • CK-2127107Cytokinetics
    Muscle weakness
  • AABPJapan JV
    with Amgen
  • ASP7035Drais
    Nocturia
  • AmbrxADC technology
  • ASP015KJanssen
    RA
  • ASP7147Drais
    IBS-d
  • ASP3291Drais
    Ulcerative colitis
  • Dificlir™ (EU) Optimer C.diff infection
  • Argamate™ Jelly Sanwa Kagaku Hyperkalemia
  • Cimzia™ UCB RA
  • PSN821/842AstraZeneca
  • RIKENCo-research for
    Alzheimer’s
  • Fully-human mAbEVEC
    Infectious disease
  • VernakalantMSD
  • TransVax™Vical
    CMV DNA vaccine
  • DPP-IV RoyaltyRoyalty Pharma
  • Perseid
  • Tivozanib AVEO RCC, etc.
  • CytoriRegenerative
    medicine tech.
  • DiannexinAlavita
    DGF in KTx
  • ASP4901Aska
    BPH
  • UMN-501/-502UMN
    Influenza vaccine
  • RegeneronExtension of
    VelocImmune license
  • OSI
  • IsavuconazoleBasilea
    Fungal infections
  • QuizartinibAmbit
    AML
  • Seattle GeneticsExtension of
    ADC collaboration
  • LinaclotideIronwood
    IBS-c
  • Xtandi™Medivation
    CRPC
  • Caduet™Pfizer
    Amlo/atorva FDC
  • Symbicort™AstraZeneca
    Asthma
  • Sumavel DosePro™Zogenix
    Acute migraine
  • PerseidJV with
    Maxygen
  • Qutenza™NeurogesX
    Neuropathic pain
  • Merger & acquisition
  • Global / multi-region collaboration
  •  
  • Regional collaboration
  • Technology / research collaboration
  • Divestiture / out-licensing

AST INST/2019/0003/FR